Archive | Other Melanoma Research

Matching tumor size to strength of immune response allows melanoma drug tailoring

PHILADELPHIA — Despite the success of immunotherapies based on blocking the programmed cell death 1 (PD-1) receptor protein in metastatic melanoma patients, more than half do not experience a lasting benefit by seeing their tumors shrink.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Understanding response and resistance to cancer therapy: Lessons learned from melanoma

Dr Wargo speaks with ecancer at AACR 2017 about understanding the mechanisms of resistance in treating tumours, considering the influence of epigenetics, the tumour microenvironment and microbiota among others.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Matching tumour size to strength of immune response allows melanoma drug tailoring

Despite the success of immunotherapies based on blocking the programmed cell death 1 (PD-1) receptor protein in metastatic melanoma patients, more than half do not experience a lasting benefit by seeing their tumours shrink.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Bacteria-derived Therapy AdVCA0848 Improves Survival in Mice with Melanoma, Study Indicates

A new therapy that activates a protein pathway to stifle melanoma tumor growth has shown promise as a treatment for the disease, a study reports.

Read the full story

Posted in Melanoma In The News, Other Melanoma Research

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories